Educational information, not medical advice — ask your doctor or midwife.
Indonesian cinnamon (Cinnamomum burmannii) is the bark-derived spice that fills most grocery store cinnamon jars in the United States and Canada. Its flavor is bolder and slightly more bitter than Ceylon cinnamon, and it rolls into a single thick layer — not the papery multi-layered quill of Ceylon. While it has long been used in Indonesian and broader Southeast Asian cooking and traditional medicine, it has gained modern scientific attention primarily for its effects on blood sugar and metabolic health.
The key active compound, cinnamaldehyde, helps mimic insulin by activating cellular glucose transporters so cells can take up sugar more efficiently. Procyanidins in the bark act on insulin receptors directly, making cells more responsive to insulin's signal. On top of that, cinnamon slows the rate at which carbohydrates are broken down in the gut, which helps flatten blood sugar spikes after meals.
Ground powder and capsules are the most practical forms for consistent daily use. Standardized extracts (often labeled as water-soluble or aqueous cinnamon extract) have been used in clinical studies specifically because they retain blood-sugar-active procyanidins while reducing coumarin. Bark sticks can be simmered into teas or broths. For supplemental use targeting blood sugar, a standardized capsule is the most reliable option.
Cinnamon has been traded and used medicinally across Asia, the Middle East, and Europe for thousands of years. Indonesian cassia was a prized commodity in ancient spice trade routes and has been central to Indonesian cuisine and traditional Jamu herbal medicine for centuries. In Jamu, it was used to warm the body, improve digestion, and support vitality. It remains the dominant commercial cinnamon globally today.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.